Hippel James — SEC insider filings

SEC reporting owner CIK 1603594. 35 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-08-07 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIO-TECHNE Corp (TECH)CFO35—65 legs · 96,626 sh · $38,963,657115

Insider filings — Hippel James

FiledFormIssuerReported transactionsSource
2026-11-034BIO-TECHNE Corp (TECH)Option exercise (M): 11,545 @ $0 · Tax withholding (F): 5,096 @ $72.66 · Option exercise (M): 11,545 (derivative) @ $0EDGAR
2026-11-024/ABIO-TECHNE Corp (TECH)Option exercise (M): 9,980 @ $0 · Tax withholding (F): 4,423 @ $72.40 · Disposition to issuer (D): 34,443 (derivative) @ $0 · Option exercise (M): 1,067 (derivative) @ $0 · Disposition to issuer (D): 12,798 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 moreEDGAR
2026-08-194BIO-TECHNE Corp (TECH)Grant/award (A): 22,438 (derivative) @ $0 · Grant/award (A): 36,459 (derivative) @ $0EDGAR
2026-08-184BIO-TECHNE Corp (TECH)Option exercise (M): 9,779 @ $0 · Tax withholding (F): 4,310 @ $72.40 · Option exercise (M): 866 (derivative) @ $0 · Disposition to issuer (D): 12,999 (derivative) @ $0 · Disposition to issuer (D): 34,982 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 moreEDGAR
2026-07-314BIO-TECHNE Corp (TECH)Option exercise (M): 62,068 @ $47.60 · Tax withholding (F): 51,024 @ $72.03 · Option exercise (M): 62,068 (derivative) @ $0EDGAR
2026-05-074BIO-TECHNE Corp (TECH)Option exercise (M): 62,000 @ $47.60 · Tax withholding (F): 56,955 @ $56.68 · Option exercise (M): 62,000 (derivative) @ $0EDGAR
2026-04-244BIO-TECHNE Corp (TECH)Option exercise (M): 62,000 @ $0 · Tax withholding (F): 56,097 @ $58.58 · Option exercise (M): 62,000 (derivative) @ $0EDGAR
2025-11-054BIO-TECHNE Corp (TECH)Option exercise (M): 13,159 @ $0 · Option exercise (M): 11,545 @ $0 · Tax withholding (F): 11,865 @ $62.57 · Option exercise (M): 13,159 (derivative) @ $0 · Option exercise (M): 11,545 (derivative) @ $0EDGAR
2025-08-194BIO-TECHNE Corp (TECH)Option exercise (M): 4,010 @ $0 · Tax withholding (F): 1,926 @ $53.60 · Option exercise (M): 4,010 (derivative) @ $0 · Grant/award (A): 29,420 (derivative) @ $0 · Grant/award (A): 14,710 (derivative) @ $0 · Grant/award (A): 37,632 (derivative) @ $0EDGAR
2025-07-314BIO-TECHNE Corp (TECH)Option exercise (M): 168,620 @ $44.33 · Tax withholding (F): 147,431 @ $58.55 · Option exercise (M): 168,620 (derivative) @ $0EDGAR
2024-11-054BIO-TECHNE Corp (TECH)Option exercise (M): 13,159 @ $0 · Tax withholding (F): 6,475 @ $75.31 · Option exercise (M): 13,159 (derivative) @ $0 · Grant/award (A): 34,634 (derivative) @ $0EDGAR
2024-08-194BIO-TECHNE Corp (TECH)Grant/award (A): 24,062 (derivative) @ $0 · Grant/award (A): 12,031 (derivative) @ $0 · Grant/award (A): 32,417 (derivative) @ $0EDGAR
2024-08-064BIO-TECHNE Corp (TECH)Option exercise (M): 53,000 @ $31.26 · Tax withholding (F): 36,076 @ $82.35 · Option exercise (M): 53,000 (derivative) @ $0EDGAR
2024-07-254BIO-TECHNE Corp (TECH)Option exercise (M): 35,000 @ $31.26 · Tax withholding (F): 24,282 @ $77.77 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2023-12-214BIO-TECHNE Corp (TECH)Option exercise (M): 47,289 @ $31.26 · Tax withholding (F): 32,966 @ $77.42 · Option exercise (M): 47,289 (derivative) @ $0EDGAR
2023-12-144/ABIO-TECHNE Corp (TECH)Grant/award (A): 13,865 (derivative) @ $0 · Grant/award (A): 37,314 (derivative) @ $0EDGAR
2023-11-034BIO-TECHNE Corp (TECH)Grant/award (A): 26,318 (derivative) @ $0EDGAR
2023-08-174BIO-TECHNE Corp (TECH)Grant/award (A): 12,798 (derivative) @ $0 · Grant/award (A): 34,442 (derivative) @ $0 · Grant/award (A): 45,923 (derivative) @ $0EDGAR
2023-08-084BIO-TECHNE Corp (TECH)Option exercise (M): 12,876 @ $0 · Tax withholding (F): 6,335 @ $82.17 · Option exercise (M): 12,876 (derivative) @ $0EDGAR
2022-08-174BIO-TECHNE Corp (TECH)Grant/award (A): 2,728 (derivative) @ $0 · Grant/award (A): 8,479 (derivative) @ $0 · Grant/award (A): 11,305 (derivative) @ $0EDGAR
2022-08-094BIO-TECHNE Corp (TECH)Option exercise (M): 3,938 @ $0 · Tax withholding (F): 1,938 @ $382.97 · Option exercise (M): 3,938 (derivative) @ $0EDGAR
2021-11-034BIO-TECHNE Corp (TECH)Option exercise (M): 8,822 @ $125.05 · Sale (S): 3,566 @ $525.61 · Sale (S): 2,880 @ $526.50 · Sale (S): 1,433 @ $527.50 · Sale (S): 943 @ $528.55 · Option exercise (M): 200 @ $125.05 · +3 moreEDGAR
2021-11-014BIO-TECHNE Corp (TECH)Sale (S): 100 @ $525.18 · Option exercise (M): 662 @ $125.05 · Sale (S): 662 @ $525.23 · Option exercise (M): 662 (derivative) @ $0EDGAR
2021-09-074BIO-TECHNE Corp (TECH)Option exercise (M): 10,000 @ $106.59 · Sale (S): 9,993 @ $507.22 · Sale (S): 7 @ $509.17 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-08-104BIO-TECHNE Corp (TECH)Option exercise (M): 3,383 @ $0 · Tax withholding (F): 1,665 @ $481.82 · Option exercise (M): 10,000 @ $106.59 · Sale (S): 5,200 @ $477.69 · Sale (S): 1,800 @ $478.58 · Sale (S): 1,300 @ $479.96 · +10 moreEDGAR
2021-07-144BIO-TECHNE Corp (TECH)Option exercise (M): 10,000 @ $106.59 · Sale (S): 600 @ $451.07 · Sale (S): 751 @ $451.95 · Sale (S): 788 @ $453.21 · Sale (S): 662 @ $454.15 · Sale (S): 1,773 @ $455.57 · +9 moreEDGAR
2021-06-094BIO-TECHNE Corp (TECH)Option exercise (M): 9,942 @ $106.59 · Sale (S): 1,507 @ $419.88 · Sale (S): 2,029 @ $420.66 · Sale (S): 2,396 @ $421.93 · Sale (S): 2,000 @ $422.81 · Sale (S): 1,700 @ $423.74 · +2 moreEDGAR
2021-02-174BIO-TECHNE Corp (TECH)Option exercise (M): 10,000 @ $106.59 · Sale (S): 9,400 @ $400.32 · Sale (S): 600 @ $401.52 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-01-134BIO-TECHNE Corp (TECH)Option exercise (M): 10,000 @ $106.59 · Sale (S): 400 @ $328.68 · Sale (S): 400 @ $330.26 · Sale (S): 700 @ $331.61 · Sale (S): 2,501 @ $333.23 · Sale (S): 3,990 @ $334.39 · +2 moreEDGAR
2020-11-134/ABIO-TECHNE Corp (TECH)Option exercise (M): 7,391 (derivative) @ $0EDGAR
2020-11-124/ABIO-TECHNE Corp (TECH)Option exercise (M): 8,809 (derivative) @ $0EDGAR
2020-11-124BIO-TECHNE Corp (TECH)Option exercise (M): 3,600 @ $106.59 · Sale (S): 1,100 @ $306.81 · Sale (S): 100 @ $307.74 · Sale (S): 1,098 @ $310.55 · Sale (S): 1,002 @ $311.60 · Sale (S): 300 @ $312.58 · +5 moreEDGAR
2020-11-064BIO-TECHNE Corp (TECH)Option exercise (M): 7,100 @ $108.49 · Sale (S): 1,555 @ $272.71 · Sale (S): 2,745 @ $273.65 · Sale (S): 1,600 @ $274.53 · Sale (S): 1,200 @ $275.79 · Option exercise (M): 8,809 @ $108.49 · +12 moreEDGAR
2020-08-114BIO-TECHNE Corp (TECH)Option exercise (M): 4,438 @ $0 · Tax withholding (F): 2,184 @ $265.76 · Option exercise (M): 4,438 (derivative) @ $0EDGAR
2020-08-074BIO-TECHNE Corp (TECH)Grant/award (A): 3,219 (derivative) @ $0 · Grant/award (A): 14,360 (derivative) @ $0 · Grant/award (A): 19,147 (derivative) @ $0 · Grant/award (A): 8,325 (derivative) @ $0 · Grant/award (A): 8,325 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1603594 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs